FDA COMPLIANT QUALITY SYSTEM TO RISK-MITIGATE, DEVELOP, AND MAINTAIN SOFTWARE-BASED MEDICAL SYSTEMS
Patent №
US 11,295,261
Granted
2022-04-05
Filed 2019
Owner
FLUENT NEUROTECHNOLOGY LLP
+1 more
Lab
—
AI components
4
ml · kr · planning · hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
16423981
Apparatus and associated methods relate to a risk trace matrix engine for managing database associations, in a quality management system (QMS), between risk mitigations and features of a system having a risk-based profile. In an illustrative example, metadata may be created to associate risk mitigations with elements of a product and then metadata may be stored in a database during the design or operating lifecycle of the product, for example. The engine may dynamically build one or more trace matrices for the product design, each matrix associating risk mitigations to elements of the product design documentation. In response to any modifications that may relate to the component's specifications, for example, the engine may retrieve associated metadata and generate notifications prompting for user verification. In various implementations, such engines may advantageously reduce the risk by automatically generating traceability via a matrix of associations between features and components, which may be hardware and/or software components.
AI classification
Ownership
FLUENT NEUROTECHNOLOGY LLP
assignment · 584970672
DEEPWELL DTX
assignment · 589200332
Assignors
DOUGLAS, RYAN J.
On an employer assignment, the assignors are typically the inventors.